ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0951

Predicting Kidney Recovery After Living Kidney Donation: Insights from Integrated Scintigraphic, Biochemical, and Ultrasonographic Assessments

Session Information

Category: Transplantation

  • 2102 Transplantation: Clinical

Authors

  • Hirano, Hajime, Tokyo Joshi Ika Daigaku, Shinjuku, Tokyo, Japan
  • Inoue, Takahiro, Tokyo Joshi Ika Daigaku, Shinjuku, Tokyo, Japan
  • Hanafusa, Norio, Tokyo Joshi Ika Daigaku, Shinjuku, Tokyo, Japan
  • Azuma, Haruhito, Osaka Ika Yakka Daigaku, Takatsuki, Osaka Prefecture, Japan
Background

Accurate prediction of post-donation renal function is vital for the safety and quality of life of living kidney donors. While split renal function (SRF) by Tc-99m MAG3 scintigraphy is widely used, the combined clinical value of scintigraphic, biochemical, and ultrasonographic data remains unclear. This study provides a comprehensive, longitudinal evaluation of these multimodal assessments to identify predictors of long-term renal outcomes.

Methods

We retrospectively analyzed 34 living kidney donors (25 female, 9 male; mean age 60.5±8.2 years) who underwent nephrectomy at a single center (2021–2024). SRF and MAG3 clearance, serum creatinine, and eGFR (Japanese MDRD equation) were measured pre-donation and at 1, 6, and 12 months post-donation. Renal cortical thickness was assessed by ultrasonography. Temporal changes were analyzed using repeated-measures ANOVA, and the correlation between preoperative SRF and 12-month eGFR was examined.

Results

Preoperative SRF of the remaining kidney averaged 49.4%. Mean serum creatinine increased from 0.63 to 0.95 mg/dL at 12 months (p < 0.001). eGFR declined from 65.4 to 48.2 mL/min/1.73 m2 at 1 month, partially recovered to 51.3 at 6 months, and stabilized at 53.6 at 12 months. Relative eGFR recovery was 73.7% at 1 month, 78.5% at 6 months, and 82.0% at 12 months. MAG3 clearance increased by 16.7% between 1 and 6 months and plateaued. Significant cortical thickening was observed by ultrasonography post-donation. Preoperative SRF strongly correlated with 12-month eGFR (r = 0.65, p < 0.01), supporting its predictive value.

Conclusion

Integrating MAG3 scintigraphy, biochemical indices, and ultrasonographic markers provides a practical and noninvasive approach to predicting post-donation renal outcomes. Preoperative SRF and cortical hypertrophy are robust predictors of long-term renal function, supporting personalized risk stratification. These findings have immediate clinical implications for donor selection and follow-up. Prospective, multicenter validation is warranted.

Digital Object Identifier (DOI)